Genedata Forges Alliance with Intellicyt
News Jun 18, 2015
The firms will integrate Genedata's Screener software with IntelliCyt's iQue Screener system.
The alliance will bring Genedata's highly-scalable data analytics to IntelliCyt's high-throughput flow cytometry capabilities. The iQue Screener can analyze more than 10,000 cells or beads per second, the firm said in a statement, an order of magnitude increase over plate-based systems, with up to 15 parameters per cell.
"Advanced computational analysis solutions are required to handle the quantity and complexity of data obtained in high-throughput flow cytometry experiments in large-scale screening applications," Janette Phi, chief business officer at Albuquerque, New Mexico-based IntelliCyt, said in a statement. "The combined solution of Genedata Screener software and the IntelliCyt iQue Screener platform addresses this unmet industry need. Our solution provides a powerful option for our customers for robust and accurate data analysis across all plates from high-throughput flow cytometry data generated by iQue."
The combined technologies will enable researchers to screen large libraries of drug candidates against suspension cells and multiplex beads in phenotypic drug discovery, antibody screening, immunology, and biomarker research, the firms said.
How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?News
Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE